Literature DB >> 14991926

Long-term effect on carcinoma of esophagus of distal subtotal gastrectomy.

Yu-Ping Chen1, Jie-Sheng Yang, Di-Tian Liu, Yu-Quan Chen, Wei-Ping Yang.   

Abstract

AIM: To investigate the surgical treatment and long-term survival for patients with carcinoma of esophagus after distal subtotal gastrectomy.
METHODS: Resections of the tumor through left thoracotomy were performed in 85 patients with esophageal carcinoma following distal subtotal gastrectomy. The procedure involved preserving the left short gastric artery and transporting the residual stomach, the spleen and tail of the pancreas into the left thoracic cavity, and using the residual stomach to reconstruct the alimentary tract.
RESULTS: The resectable rate was 91.8%, complication rate 10.3%, and no death occurred in the postoperative period. The 1-, 3-, 5-, and 10-year survival rates were 85.7%, 50.7%, 30.6% and 18.8%, respectively.
CONCLUSION: Surgical resection is the optimal management method for the patients with esophageal carcinoma after distal subtotal gastrectomy. The reconstruction of digestive tract using anastomosis of the esophagus and the residual stomach is not only simple but also can achieve a better curative effect, promoting the digestive function and improving the quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 14991926      PMCID: PMC4716897          DOI: 10.3748/wjg.v10.i5.626

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  Surgical treatment for thoracic esophageal carcinoma in patients after gastrectomy.

Authors:  H Kato; Y Tachimori; H Watanabe
Journal:  J Surg Oncol       Date:  1992-10       Impact factor: 3.454

2.  Oesophageal squamous cell carcinoma after gastrectomy for benign ulcer disease.

Authors:  N Y Hsu; C Y Chen; J T Chen; C P Hsu
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1996

3.  Possible association between gastrectomy and subsequent development of esophageal cancer.

Authors:  M Maeta; S Koga; T Shimizu; K Matsui
Journal:  J Surg Oncol       Date:  1990-05       Impact factor: 3.454

4.  Operative technique for carcinoma of the oesophagus after distal subtotal gastrectomy: a new method using the residual stomach to reconstruct the alimentary tract.

Authors:  S J Lu; B X Chen
Journal:  Aust N Z J Surg       Date:  1990-09

Review 5.  Malignancy following surgery for benign peptic disease: a review.

Authors:  C P Caygill; M J Hill
Journal:  Ital J Gastroenterol       Date:  1992-05

6.  [Long-term results of surgical resection of early esophageal and cardiac carcinomas].

Authors:  L F Shao
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1993-03

7.  Oesophageal cancer in gastric surgery patients.

Authors:  C P Caygill; M J Hill; J S Kirkham; T C Northfield
Journal:  Ital J Gastroenterol       Date:  1993-05

8.  Squamous cell carcinoma of the esophagus after partial gastrectomy.

Authors:  M Tachibana; S Abe; H Yoshimura; K Suzuki; H Matsuura; N Nagasue; T Nakamura
Journal:  Dysphagia       Date:  1995       Impact factor: 3.438

9.  [Surgical treatment of esophageal cancer in four patients after gastrectomy for gastric cancer].

Authors:  M Takemura; M Higashino; H Osugi; T Tokuhara; S Kaseno; H Kinoshita
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1996-01

10.  Risk of cancer following partial gastrectomy for benign ulcer disease.

Authors:  G Lundegårdh; H O Adami; C Helmick; M Zack
Journal:  Br J Surg       Date:  1994-08       Impact factor: 6.939

View more
  2 in total

1.  Gastric carcinoma with osteoblastic differentiation.

Authors:  Fatih Selcukbiricik; Deniz Tural; Elif Tuba Senel; Sergülen Dervisoglu; Süheyla Serdengecti
Journal:  Int J Surg Case Rep       Date:  2012-07-20

Review 2.  Carcinosarcoma of the stomach: a case report and review of the literature.

Authors:  Tomislav Randjelovic; Branka Filipovic; Darko Babic; Vesna Cemerikic; Branislav Filipovic
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.